Tata Steel Board Clears Neelachal Merger, $2 Billion Investment and and Medica Hospital acquisition

Mumbai / Jamshedpur: Tata Steel Limited announced a series of key decisions on Tuesday after its Board meeting, outlining a clear strategy focused on consolidation, global expansion, and diversification.

The Board approved a Scheme of Amalgamation between Tata Steel and its wholly owned subsidiary, Neelachal Ispat Nigam Limited, along with their respective shareholders. The company will implement the merger under the provisions of the Companies Act, 2013, and other applicable laws, subject to regulatory approvals. Through this move, Tata Steel aims to streamline operations and improve efficiency in its domestic steel business.

In another major decision, the Board approved an investment of up to USD 2 billion (approximately Rs 18,488 crore) in its wholly owned foreign subsidiary, T Steel Holdings Pte. Ltd. The company will invest through subscription to equity shares in one or more tranches starting from the financial year 2026–27. With this investment, Tata Steel plans to strengthen its overseas operations and drive long-term growth in international markets.

Expanding beyond its core steel business, Tata Steel also approved the acquisition of a stake in Medica TS Hospital Private Limited from Manipal Hospitals Eastern India Private Limited. The deal includes 7,40,000 equity shares representing a 49% stake and more than 2.30 crore optionally convertible redeemable preference shares. Upon completion, the acquisition will make Medica TS Hospital a wholly owned subsidiary of Tata Steel. The transaction, valued at around Rs 1.49 crore, remains subject to necessary approvals.

The company confirmed that it took all decisions in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board meeting began at 2 pm and concluded at 5:15 pm.

These decisions highlight Tata Steel’s strategy to strengthen its core business, expand its global footprint, and diversify into new sectors such as healthcare, reinforcing its position as a diversified multinational enterprise.